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ABSTRACT
Objective: Glutathione is an important antioxidant compound that is added to various cosmetic preparations. This study compared the stability, 
antioxidant activity, and penetration of glutathione creams formulated with and without transfersome, a commonly used carrier system.
Methods: The particle size of the transfersome was 55.65 nm, with a polydispersity index of 0.398 and an entrapment efficiency of 66.22%. During 
cycling and centrifugal testing, the creams (with and without transfersome) did not change color or demonstrate phase separation. Chemical stability 
analyses of the products were performed using high-performance liquid chromatography.
Results: The remaining glutathione content in the transfersome cream was 83.44%, while that of the non-transfersome cream was 47.92%. In the 
penetration test using Franz diffusion cells, the transfersome cream demonstrated a cumulative penetration of 4474.44 µg/cm2, with a cumulative 
concentration percentage of 39.60% and a flux of 510.38 µg/cm−2h−1. In contrast, the non-transfersome cream demonstrated a cumulative penetration 
amount of 2793.80 µg/cm2, with a cumulative concentration percentage of 24.73% and a flux of 340.12 µg/cm−2h−1. In addition, the IC50 value of the 
transfersome cream preparation was 11.89 µg/mL, while that of the non-transfersome preparation was 15.57 µg/mL.
Conclusion: Our findings indicate that the use of transfersome increases the stability and penetration of glutathione in cream preparations.
Keywords: Glutathione, Transfersome, Cream, High-performance liquid chromatography, Optimization, Stability test, Antioxidant activity test, 
Penetration test.
INTRODUCTION
Glutathione is a potent antioxidant and is a thiol tripeptide compound 
found in every cell of the human body. Glutathione consists of three 
amino acids, namely, L-glutamine, L-cysteine, and L-glycine connected 
by gamma peptide bonds between the amine cysteine group (which is 
attached to the peptide bond by glycine) and the carboxyl group of the 
glutamate side chain [1]. In the body, two forms of glutathione exist 
reduced glutathione (GSH) and oxidized glutathione (GSSG) [2].
Glutathione in aqueous solutions is very unstable and easily decomposes, 
while GSSG is less susceptible to decomposition in aqueous solutions 
and is suitable for use in liquid form [3]. Glutathione can experience 
a decrease in quality due to the influence of heat, oxygen, and light, 
which can cause unpleasant odors such as sulfur odors and decreased 
preparation content [4]. Glutathione in topical preparations can be 
used to treat various skin issues, including dry and dull skin, the loss of 
elasticity, and the appearance of excessive lines and wrinkles [5].
Transfersome was first introduced in 1991 by Gregor Cevc. The term 
transfersome comes from the Latin transferre, which means to carry 
the whole, and from the Greek soma, which means the body [6]. 
Transfersome, in the broadest sense, is a compound or aggregate that 
very easily adapts and responds to its environment. In general, 
transfersome has a structure consisting of a hydrophilic part (aqueous 
layer) as its core surrounded by a hydrophobic part (double lipid layer) 
that can carry active substances with various solubilities [7].
Transfersome as a carrier in a given formulation has a number of 
advantages, including the ability to change the shape of the formulation 
so it can pass through narrow pores, improved penetration, the ability 
to carry active substances of a large solubility range efficiently (up to 
90%), the ability to make compounds with a high molecular weight 
low, and the ability to release compounds slowly and gradually. In this 
study, we compared the stability, antioxidant activity, and penetration 
of glutathione creams formulated with and without transfersome, a 
commonly used carrier system.
MATERIALS AND METHODS
Ingredients
The materials used were glutathione standard (Jincheng Pharm, 
China); Emuldage SEPF (BASF, Germany); Cutina GMS (BASF, Germany); 
Isopropyl Myristate (BASF, Germany); Lanette O (BASF, Germany); 
Propylene Glycol (BASF, Germany); Glycerin (Merck, Germany); Cetiol 
CC (BASF, Germany); Myritol (BASF, Germany); Phosphatidylcholine 
(Merck, Germany); Tween 80 (Merck, Germany); Sodium Phosphate 
by Anhydrous (Merck, Germany); Potassium Dihydrogen Phosphate 
(Merck, Germany); Sodium Metabisulfite (Merck, Germany); 
Dichloromethane (Merck, Germany); DPPH (Merck, Germany); Diethyl 
Ether (Merck, Germany); and Aquadest (Brataco).
Tools
High-performance liquid chromatography (Shimadzu, Japan) with an 
LC-20AT model equipped with a SPD 10A (200 nm) UV–Vis detector; 
Column C18 (250 cm × 4.6 mm × 5 µm); LC-Solution data processors 
and CBM 102 integrators; UV–Vis spectrophotometry (Shimadzu UV-
1601 and Jasco); Microsyringe 10 ul (Hamilton Co.Nevada, America); 
rotary vacuum evaporator (Hahn Shin, China); centrifugator (Hettich 
Zentrifugen EBA 200, America); Sonicator (Branson 3200, America); 
rotary vacuum evaporator (Buchi, Switzerland); Particle Size Analyzer 
(Malvern Zetasizer, UK); Climatic chamber (Nuve Sanayi Malzemeleri 
Imalat ve Tic. A.S., Turkey); Oven (Memmert); Refrigerator (GEA, 
Germany); Cell Diffusion Franz; Analytical balance; Stirer; PH meter; 
Fume hood; Freezer; Separating funnel; Glass beads; Micropipettes; and 
glassware commonly used in quantitative analysis.
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Steps
Preparing the solvent phase
Approximately 6.8 g of potassium dihydrogen phosphate was carefully 
weighed and then dissolved in 1000 mL of aquadest. The pH was then 
adjusted with dilute phosphoric acid (1:10) to pH 3.0.
Preparing the glutathione standard master solution
10 mg of glutathione standard was carefully weighted, then diluted 
with a buffered phosphate of pH 3.0 to concentrations of 1000 µg/mL, 
100 µg/mL, and 10 µg/mL.
Determination of optimum analysis conditions
Before high-performance liquid chromatography (HPLC) analysis, the 
maximum wavelength was determined using UV–Vis spectrophotometry. 
The standard solution used for examining the maximum wavelength was 
10 µg/mL. The determination of the optimum analysis conditions was 
performed through varying the flow rate at 0.6, 0.8, 1.0, and 1.2 mL/min.
System suitability test
The solution for the system suitability test was a standard glutathione 
solution at a concentration of 10 µg/mL, which was injected into the 
HPLC 6 times.
Selectivity test
The solution used for the selectivity test was a placebo or cream base 
that did not contain glutathione. The cream base used was 25 mg, which 
was sonicated for 15 min. After sonication, the cream was transferred 
into a centrifugation tube and vortexed for 5 min. After that, it was 
centrifuged at 4000 rpm for 15 min. The formed supernatant was then 
taken and filtered with a Whatman nylon filter syringe (0.45 µm).
Linearity test
The solution used for the linearity test was a standard glutathione 
solution at concentrations of 10 µg/mL, 20 µg/mL, 40 µg/mL, 50 µg/mL, 
80 µg/mL, and 150 µg/mL.
Accuracy and precision test
Accuracy and precision tests were performed with glutathione 
concentrations of 80%, 100%, and 120%. For example, an 80% 
glutathione concentration was made by mixing 8 mg of standard 
glutathione with a cream base of up to 500 mg. The 100% concentration 
was made by mixing 10 mg of standard glutathione with a cream base 
of up to 500 mg. The 120% concentration was made by mixing 12 mg 
of standard glutathione with a cream base of up to 500 mg. For each 
concentration, we weighed the sample to ± 25 mg and then placed it 
into a 10-mL volumetric flask and sonicated it for 15 min, with final 
placement into a centrifuge tube. Before centrifugation, the solution 
was vortexed for 5 min then centrifuged at 4000 rpm for 15 min. The 
supernatant from each concentration was filtered using 0.45 µm nylon 
syringe filters. The 80% and 120% concentrations were injected into 
the HPLC 3 times, with the 100% concentration was injected 6 times.
Transfersome formulation and optimization of the sodium 
phosphate-buffered
The phosphate-buffered solution at pH 7.4 was made by mixing 50 mL 
of 0.2 M potassium dihydrogen phosphate with 39.1 mL 0.2 N sodium 
hydroxide in a 200-mL volumetric flask, then increasing the volume 
gradually with aquadest to 200 mL. Previously, 0.2 M potassium 
dihydrogen phosphate was made by weighing 1.36 g of potassium 
dihydrogen phosphate powder, dissolved in distilled water in a 50-mL 
volumetric flask, and a sufficiently small volume was added to reach the 
measuring flask limit. To prepare the 0.2 N sodium hydroxide solution, 
sodium hydroxide was weighed to 0.4 g, then dissolved in 50 mL of 
distilled water. The pH was checked using a pH meter. Data in Table 1.
Transfersome preparation
Transfersome was prepared by dissolving phosphatidylcholine and 
tween 80, then dissolving it into dichloromethane as much as 15 mL. 
After complete dissolution, the solution was placed into a round-
bottomed flask and applied with a rotary evaporator at 40°C with an 
initial speed of 50 rpm. This speed was increased by 25 rpm every 
5 min to reach 150 rpm to remove any organic solvents for 60 min. 
The solution was then flowed with nitrogen gas for 2 min and left for 
24 h in a closed state. Glutathione (0.6 gram) was then dissolved with 
phosphate buffer (pH 7.4) as much as 12 mL; then the solution was 
hydrated to a thin layer in a round-bottomed flask. The flask was then 
placed on a rotary evaporator without a vacuum at a temperature of 
30oC and rotated with an initial speed of 50 rpm; this speed was then 
increased by 25 rpm every 5 min to reach 150 rpm with the help of glass 
beads that easily peel off. The resulting suspension was removed from 
the rotary evaporator and then sonicated for 10 min.
Particle size test
This test used a particle size analyzer at 4°C. One drop of the sample 
from each transfersome formulation was dispersed in 10 mL aquadest, 
then placed in a cuvette to the ideal limit specified.
Entrapment efficiency test
Absorption efficiency was measured by calculating the total and free 
glutathione concentration. The total glutathione concentration was the 
concentration of glutathione that was absorbed and free in suspension. 
To separate the free glutathione, a centrifuge was used at a speed of 
13,000 rpm for 2 h at 4°C. The supernatant formed then contained the free 
glutathione and was measured using HPLC at a wavelength of 200 nm. 








Accelerated stability testing was performed by inserting a number of 
cream samples into plastic pots. Then they were stored in a climate 
chamber at storage conditions of 40±2°C, with humidity set at 75±5% 
RH. The creams were sampled at 0, 1, 2, and 3 months, followed by HPLC 
analysis. The samples were weighed as much as 25 mg for stability tests 
at 0, 1, 2, and 3 months, then placed in a 10-mL volumetric flask with 
solvents added to the limit. The solution was then sonicated for 15 min 
and placed into a centrifugation tube. Before centrifuging, the solution 
was vortexed for 5 min. The centrifuge speed was 4000 rpm for 15 min. 
The supernatant was taken and filtered using a Whatman nylon filter 
syringe (0.45 µm).
Stability cycling test
This stability test was performed by storing the cream at 4°C for 24 h, 
then removing it and placing it into an oven at a temperature of 40±2°C 
for 24 h; the treatment consisted of one cycle. This experiment was 
repeated for as many as six cycles over 12 days. The physical condition 
of the cream such as color, smell, and presence or absence of phase 
separation was then observed.
Centrifugal test
This stability test was intended to determine whether phase separation 
occurred in the cream samples. Cream samples were centrifuged for 
3750 rpm for 5 h.










Glutathione 0.6 0.6 0.6
Phosphatidylcholine 1.35 1.275 1.125
Tween 80 0.15 0.225 0.375
Buffer phosphate 7.4 12 12 12
Total 15 15 15
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Antioxidant activity test and making the DPPH stock solution
Five milligrams DPPH was dissolved in 100 mL of methanol to obtain a 
concentration of 50 µg/mL. The solution was examined for its maximum 
wavelength using UV–Vis Spectrophotometry.
Making a blank solution
A total of 1 mL of the methanol was added to 3 mL DPPH, then vortexed 
for 20 s and incubated for 30 min. After 30 min, the absorbance was 
measured with the selected maximum wavelength.
Making sample solutions
The cream samples (500 mg containing 10 mg glutathione) were 
dissolved in 20 mL of methanol and then sonicated for 10 min. After 
sonification, the solution was centrifuged at 4000 rpm for 10 min. The 
centrifuged filtrate was then diluted to form concentrations of 3 µg/mL, 
5 µg/mL, 8 µg/mL, 10 µg/mL, 15 µg/mL, and 20 µg/mL. As much as, 
1 mL of each sample was added to 3 mL DPPH, then this solution was 
vortexed for 20 s and incubated for 30 min. After 30 min, the absorbance 
was measured with the selected maximum wavelength.
Determination of the % inhibition value
From the absorbance obtained from the blank solution and the sample, 





Determination of IC50 values
After the % inhibition value was obtained, the data were plotted 
into a graph with concentration as the X-axis and % inhibition as the 
Y-axis. From the graph, we then obtained a linear regression equation 
in the form of y = a + bx, with the value of x representing the IC50 
value.
Penetration test
The penetration test was performed using the Franz Diffusion Cell tool. 
The test membrane used was the skin of female Sprague Dawley mice, 
aged 8–10 weeks, with a weight of ±200 g. The mice used in the experiment 
had received a certificate of ethical review from the Health Research 
Ethics Committee of the Faculty of Medicine, University of Indonesia, 
Cipto Mangunkusumo Hospital. Before use, the skin of the mouse was 
shaved and cleaned of sticking fats. The area of the diffusion membrane 
was 1.77 cm2, with a compartment volume of 15 mL. The compartment 
was filled with phosphate buffer at pH 7.4 and stirred constantly with 
a magnetic stirrer at a speed of 250 rpm at 37±5°C. Transfersome and 
non-transfersome cream was weighed as much as 1 g and applied to the 
skin. A total of 1 mL of sample was taken from the receptor compartment 
periodically for 8 h using a syringe and replaced with the same amount of 
phosphate buffer solution at pH 7.4. The sample was taken in the 10th min 
at 30; 60 (1 h); 90; 120 (2 h); 180 (3 h); 240 (4 h); 300 (5 h); 360 (6 h); 
420 (7 h); and 480 (8 h) min. The samples obtained were measured for 
absorption using HPLC at a wavelength of 200 nm.
RESULTS AND DISCUSSION
Extraction
The wavelength used for HPLC analysis was 200 nm, because the 
maximum wavelength can cause maximum absorbance. Based on these 
data, the selected flow rate was 0.8 mL/min. Even though the flow rate 
at 1.0 mL/min had a larger peak area, the tailing factor of the flow rate 
was larger than that at 0.8 mL/min. In addition, the retention time was 
similar to that shown on USP 41 NF 36, which is 5 min (Tables 2-3).
The system suitability test was needed because there were possible 
disturbing factors due to variations in the analysis tools and techniques 
used. The system suitability test was performed 6 times at a concentration 
of 10 µg/mL to produce a coefficient of variation. Based on the result of 
the analysis, the coefficient of variation obtained was 0.34% for the area, 
0.34% for retention time, 1.18% for tailing factor, 0.90% for theoretical 
plate number (N), and 0.90% for the column efficiency value (height 
equivalent to a theoretical plate). The coefficient value of variation 
obtained meets the requirements, which is <2% (Table 4).
The linear relationship is shown by the correlation coefficient 
parameters for the linear regression analysis of y = a + bx. From the 
calibration curve, the linear regression value obtained y = 14050x + 
68846. With a correlation coefficient of 0.9992, the glutathione standard 
meets the linearity requirements because the correlation coefficient 
value is close to 1 or > 0.9990. Based on the results of the glutathione 
standard linearity test, the detection limit value was 6.79 µg/mL, and 
the quantitation limit value was 22.63 µg/mL. The smaller the limit of 
detection and limit of quantification values are, the more sensitive the 
analytical method. The data shown in Table 5 and Fig. 1.





Table 3: Correlation of flow rate, peak area, retention time, tailing factor theoretical plate, and HETP
Flow rate (mL/min) Peak area (µV/s) Retention time (min) Tailing factor (Tf) Theoretical plate (Plat) HETP (cm)
0.6 214,356 6.250 1.454 4781 31.373
0.8 177,847 5.747 1.219 4015 37.361
1.0 128,126 3.719 1.347 3539 42.389
1.2 107,924 3.108 1.334 3097 48.438
HETP: Height equivalent to a theoretical plate
Table 4: Result of the system suitability test
Concentration (µg/mL) Peak area (µV/s) Retention factor (min) Tailing factor (Tf) Theoretical plate (Plat) HETP (cm)
10 163,377 5.701 1.255 5223 28.720
162,051 5.685 1.243 5249 28.576
163,581 5.671 1.246 5259 28.525
163,084 5.661 1.242 5294 28.333
163,455 5.67 1.212 5361 27.977
163,144 5.646 1.236 5272 28.450
Average 163,115.33 5.672 1.239 5276,33 28.430
RSD 554.1295 0.0190 0.0146 47.7312 0.2567
0.34 0.34 1.18 0.9 0.9
HETP: Height equivalent to a theoretical plate
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The selectivity test aims to assess the ability of a method to measure a 
given substance specifically with the possibility of other components in 
the sample matrix. The results of the chromatogram obtained are then 
compared with those of the standard solution. Based on the results of 
this analysis, in the chromatogram of the placebo solution, there was 
no interference in the peak of other compounds around the glutathione 
retention time (Fig. 2).
Accuracy and precision tests were performed by mixing a number of 
standard glutathione solutions with the cream bases. This is called 
the simulation method. Calculation of the accuracy is performed 
by calculating the recovery value (% UPK). The recovery value is 
calculated by comparing the results of the analysis with the actual 
results. Based on the results of the study in Table 6, the %UPK at a 
concentration of 40 µg/mL was 101.32%, the concentration of 100% 
was 100.93%, and the concentration of 120% was 99.51%. From 
these data, the glutathione standard has a precision range between 
99.51 and 101.32%, which is in accordance with the requirements of 
98–102%. Precision testing showed that the coefficient variation at a 
concentration of 50 µg/mL was <2%.
Phosphatidylcholine acts as the main constituent in the manufacture of 
multiple lipid membranes. The phosphatidylcholine used in this study 
was Phospholipon 90G. Phosphatidylcholine has both hydrophilic 
and hydrophobic groups; thus it can form a double-layered structure. 
Phosphatidylcholine was chosen because it is relatively odorless. 
The surfactant used to make the glutathione transfersome was tween 
80. Tween 80 is used as a surfactant because it also has a hydrophilic 
and lipophilic structure. Tween 80 has a long hydrocarbon chain that 
is flexible and not large enough to increase deformability. In addition, 
Tween 80 can also replace a portion of a double lipid membrane so that 
it can provide maximum deformability and make the transfersome more 
elastic. This can make vesicles easier to release the drug. In addition, 
Tween 80 is a non-ionic surfactant that is less irritant and is better 
tolerated by the body than other surfactants. Because it is a non-ionic 
surfactant, Tween 80 penetrates into the intracellular area of the stratum 
corneum, increasing fluidity and dissolving the lipid component [8-10].
Making transfersome using the layer hydration method consists of a 
thin-layer formation, with stages of hydration. The thin-layer formation 
uses a rotary evaporator with the help of a vacuum. Phospholipon and 
Tween 80 are dissolved first with dichloromethane. The temperature 
used to make transfersome is 40°C, at which the methanol as a solvent 
will evaporate. The use of a vacuum is intended to speed up the 
evaporation process of the solvents, but the vacuum is only used for a 
few moments so as not to cause a rapid evaporation process, which may 
cause uneven thin-layer formation. After the thin layer is formed, the 
thin layer is flowed with N2 gas for 2 min then stored at 4°C for 24 h to 
prevent the oxidation of lipids and maximize solvent evaporation [9].
The next stage is the hydration of the thin layer that has been formed. 
The thin layer is hydrated using a phosphate-buffered at pH 7.4. The 
vesicle layer will form spontaneously and the hydrating fluid will enter 
into the dry thin-layer lipids. In the transfersome suspension that has 
been formed, particle size reduction is done. The reduction in particle 
size was done using ultrasonication at a 10% amplitude for 10 min. The 
time used to reduce the particle size will affect the size of the particles 
formed. The longer ultrasonication time, the smaller the particle 
size; however, if the ultrasonication time is too long, it can cause the 
oxidation and precipitation of phospholipids.
Table 7 shown the Z-average particle size for formulation 1 was 
55.65 nm; formulation 2 was 63.56 nm; and formulation 3 was 135.7 nm. Fig. 1: Calibration curve of the glutathione standard
Table 5: Results of the linearity test
Concentration (µg/mL) Peak area (µV/s) yi=a+bx (y−yi)2 Residual standard deviation LOD (µg/mL) LOQ (µg/mL)
10 188,853 209346 419963049
20 326,886 349846 527161600
40 637,274 630846 41319184 31789.48 6.79 22.63
50 824,840 771346 2861608036
80 1,189,985 1192846 8185321
150 2,162,780 2176346 184036356
Total 4042273546
LOD: Limit of detection, LOQ: Limit of quantification
Table 6: Results of the accuracy and precision test
Concentration (µg/mL) Peak area (µV/s) Measured concentration (µg/mL) Recovery (%) Average (%) RSD KV (%)
637,364 40.46 101.16










60 (120%) 907,031 59.66 99.43 99.51 0.1006 0.01
908,677 59.77 99.62
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The Z-average value was used to determine the particle size because 
the Z-average is the main and most stable parameter produced by the 
DLS method. Based on these data, F1 had the smallest particle size. 
This shows that the greater the concentration of phosphatidylcholine, 
the smaller the particle size obtained, and the greater the amount of 
surfactant, the greater the particle size obtained (Fig. 3).
The polydispersity index (PDI) value that can be obtained by the DLS 
method is in the range 0–0.6. If the PDI value obtained is small or close 
to 0, the spread of the particle size is evenly distributed or homogeneous. 
Whereas, if the IPD value obtained >0.6, samples have an increasingly 
broad distribution value [11]. PDI values can increase with increasing 
particle size because large particles tend to aggregate. From the results 
of the adsorption efficiency test, the greater the amount of phospholipids 
used, the greater the absorption efficiency. If the amount of phospholipids 
increases, the formation of the vesicles will also increase so that the 
absorption efficiency will be more optimal. In addition to the decreasing 
surfactant concentration, the absorption efficiency is even greater.
The purpose of this cycling test was to accelerate the changes in 
storage conditions that usually occur under normal conditions so that 
the preparation will experience varying levels of stress. The physical 
appearance of each glutathione preparation was observed before and 
after the test. The physical transfersome glutathione cream did not 
change color and still smelled of phosphatidylcholine. Whereas the 
non-transfersome cream did not change color, but there was a slight 
smell of sulfur in the cream preparation. However, from the two creams, 
no phase separation was observed and they remained homogeneous. 
Thus, it can be concluded that both creams are physically stable; 
however, glutathione transfersome creams appear to be more stable 
than non-transfersome creams.
This centrifugation test was likened to the gravitational force that will 
be received by a number of creams for 1 year of storage. Based on the 
results of the experiment, the transfersome glutathione cream and non-
transfersome cream after centrifugation did not show any separation of 
the water phase and oil phase. The creams were likely protected from 
phase separation because of the use of emulsifying agents, which served 
to maintain the cream preparation. In addition, the homogenization 
process can also prevent separation. Our results indicated that both 
creams can withstand the force of gravity for 1 year.
In cosmetic preparations, the accelerated stability test can be performed 
in 30 days or 90 days, but for chemical stability and determining shelf 
life, it is recommended to carry out testing for a minimum of 3 months 
with the same conditions as in pharmaceutical products [12] (Gianeti 
et al. 2012). The accelerated stability test was performed within 
3 months as previously performed by Padamwar 2006 and Gianeti 2012.
The amount of glutathione remaining from each cream decreased with 
increasing testing time. This is because glutathione is easily oxidized, 
with the thiol group easily oxidized to a disulfide group, which causes 
the glutathione to lose its antioxidant activity [13]. In addition, it can 
be caused by glutathione instability in oil cream formulations exposed 
to water and at high storage temperatures. Glutathione in the pH range 
of 5.0–8.0 can lose 10–15% of its level at room temperature storage, 
while storage at temperatures below 15°C, the glutathione lost is 
about 0–5% [14]. Reduced glutathione levels can also result because 
glutathione can be oxidized by oxygen molecules and the presence of 
metals (such as iron) in the preparation. From this accelerated stability 
test, we were able to determine the value of the shelf life for both creams 
using a zero-order reaction. The shelf life for the transfersome cream 
was determined to be 3.5 months, while that for the non-transfersome 
cream was 1.1 months. Result shown in Table 8 and Fig. 4.
Although the glutathione in this study was formulated in the form 
of transfersome, the storage period appears to be reduced. This is 
Fig. 2: Results of the selectivity test
Fig. 3: Transfersome suspensions
Table 7: Results of transfersome optimization
Formula Z-average (nm) PDI (nm) Efficiency entrapment (%)
F1 55.65 0.398 66.22
F2 63.56 0.406 64.39
F3 135.7 0.417 61.14
PDI: Polydispersity index
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probably due to the leakage process that occurs in the transfersome 
vesicles, thereby reducing the entrapment efficiency of glutathione. 
Transfersome vesicles containing lipids can degrade with increasing 
temperature. In addition, chemical degradation processes such as 
hydrolysis and oxidation occur in double lipid layers and can cause the 
formation of short-chain lipids that can form membrane-soluble lipid 
compounds that affect the stability of the transfersome vesicles [15].
After measuring the absorbance values, we determined the % 
inhibition value and obtained the linear regression equation, which 
was y = 2.8294x + 16.349 for the transfersome cream and y = 2.5925x 
+ 96432 for the non-transfersome cream. From the linear regression 
equation, the IC50 value for the transfersome cream was determined 
to be 11.89 µg/mL, while that for the non-transfersome cream was 
15.57 µg/mL. Based on these results, we determined the antioxidant 
status of each cream based on the criteria of Phongpaichit 2007. 
Indeed, if the IC50 > 250 µg/mL the antioxidants are not active; IC50 
> 100–150 µg/mL are weak antioxidants; IC50 > 50100 µg/mL are 
moderate antioxidants; IC50 10–50 µg/mL are strong antioxidants; 
and IC50 < 10 µg/mL are very strong antioxidants. Result shown in 
Tables 9-10 and Fig. 5-6.
Fig. 5: Results of the centrifuge test
Fig. 6: Transfersome and non-transfersome cream
Fig. 4: Results of the cycling test
Table 8: Results of the accelerated stability test
Transfersome cream Non-transfersome cream
Month Recovery (%) Month Recovery (%)
0 99.92 0 99.84
1 96.97 1 77.78
2 89.78 2 59.90
3 83.44 3 47.92
Table 9: Results of the antioxidant activity test
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The in vitro penetration test had two main parameters, namely, the 
cumulative amount of the penetrated substance (µg/cm2) and the 
penetration rate (flux) [9]. Flux values are obtained from the slope of 
the line or the slope of the linear curve in steady-state and are obtained 
from a comparison between the cumulative amounts of penetration to 
time. Based on the data, it can be seen that the cumulative concentrated 
amount in the transfersome preparations is greater than that of the non-
transfersome preparations. It can also be seen that the transfersome 
preparations have higher flux than the non-transfersome preparations. 
The cumulative amount of penetration can be influenced by factors 
such as the composition of the vesicles, vesicle size, membrane fluidity, 
elasticity, absorption efficiency, and method of manufacture [15].
The transfersome preparation contains phospholipids with a high 
affinity for biological membranes so that the phospholipid vesicles 
can join the intracellular lipid layer, which results in increased 
transfersome permeability. This can result in a greater transfer of the 
cream permeation compared with non-transfersome creams [9]. In 
addition, transfersome contains a surfactant that is an edge activator 
that functions to destabilize vesicles and increase deformability so that 
it allows increased glutathione penetration. Vesicles act as carriers 
of substances, where intact vesicles penetrate the stratum corneum 
under the influence of the transcutaneous hydration gradient. With 
the ability of vesicles to penetrate the stratum corneum spontaneously, 
the permeation ability of the transfersome is increased. Phospholipid 
vesicles serve to penetrate the stratum corneum and then modify the 
lipids between cells so as to increase overall fluidity, which causes an 
increased amount of glutathione to penetrate the skin.
CONCLUSION
The optimum analytical conditions for analyzing glutathione in anti-
aging cream preparations involved using an HPLC system with a C18 
column and a UV–Vis detector, with an optimum wavelength of 200 nm 
and a flow rate of 0.8 mL/min. These conditions are in accordance with 
the requirements proposed, where linearity, selectivity, and accuracy 
and precision testing met the required criteria. Glutathione formulated 
as transfersome has a ratio of phosphatidylcholine to tween 80 of 90:10. 
This is because in comparison, these transfersome preparations have a 
small particle size and PDI, with a high absorption efficiency.
The results of the accelerated stability test showed that the amount 
of glutathione remaining in the cream transfersome preparations 
was 83.44%, while that of the non-transfersome cream was 47.92%. 
The results of the cycling test and the centrifugal test showed that 
the transfersome and non-transfersome preparations had no color 
change or phase separation and were resistant to gravity for 1 year of 
storage. However, for the non-transfersome cream, during the cycling 
test, a small amount of sulfur odor was detected from the preparation. 
In the transfersome and non-transfersome creams, the glutathione 
preparations were determined to have high antioxidant activity. In 
addition, penetration test results showed that the transfersome cream 
was able to increase the cumulative amount and flux of the penetrated 
glutathione better than the non-transfersome cream.
After this study, the cream preparations were stored at temperatures 
below 15°C so that the physical and chemical stability of the cream 
and the compounds contained could be maintained during the storage 
period, given the volatile nature of the glutathione compound. In 
addition, future studies are necessary to analyze other compounds that 
may be present in the formulations, including by-products of oxidized 
glutathione.
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Total penetration cumulative 
(µg/cm2)
4474.44 2793.79
Total penetration cumulative 
(%)
39.60 24.73
Fluks (µg/cm−2h−1) 510.38 340.12
